102 related articles for article (PubMed ID: 12808889)
1. SomatoKine. Insmed.
Norman P
Curr Opin Investig Drugs; 2003 Apr; 4(4):466-71. PubMed ID: 12808889
[TBL] [Abstract][Full Text] [Related]
2. Somatomedin-1 binding protein-3: insulin-like growth factor-1 binding protein-3, insulin-like growth factor-1 carrier protein.
BioDrugs; 2003; 17(5):375-9. PubMed ID: 14498768
[TBL] [Abstract][Full Text] [Related]
3. Mecasermin rinfabate: insulin-like growth factor-I/insulin-like growth factor binding protein-3, mecaserimin rinfibate, rhIGF-I/rhIGFBP-3.
Drugs R D; 2005; 6(2):120-7. PubMed ID: 15777106
[TBL] [Abstract][Full Text] [Related]
4. Insulin detemir. Novo Nordisk.
Barlocco D
Curr Opin Investig Drugs; 2003 Apr; 4(4):449-54. PubMed ID: 12808886
[TBL] [Abstract][Full Text] [Related]
5. Exenatide. Amylin/Eli Lilly.
Giannoukakis N
Curr Opin Investig Drugs; 2003 Apr; 4(4):459-65. PubMed ID: 12808888
[TBL] [Abstract][Full Text] [Related]
6. Eligen insulin--a system for the oral delivery of insulin for diabetes.
Hoffman A; Qadri B
IDrugs; 2008 Jun; 11(6):433-41. PubMed ID: 18509785
[TBL] [Abstract][Full Text] [Related]
7. SomatoKine: is there a use in treating growth disorders?
Kemp SF; Thrailkill KM
Curr Opin Investig Drugs; 2005 Apr; 6(4):373-7. PubMed ID: 15898344
[TBL] [Abstract][Full Text] [Related]
8. CJC-1131. ConjuChem.
Giannoukakis N
Curr Opin Investig Drugs; 2003 Oct; 4(10):1245-9. PubMed ID: 14649218
[TBL] [Abstract][Full Text] [Related]
9. Insulin glulisine. Aventis Pharma.
Barlocco D
Curr Opin Investig Drugs; 2003 Oct; 4(10):1240-4. PubMed ID: 14649217
[TBL] [Abstract][Full Text] [Related]
10. MK-767. Kyorin/Banyu/Merck.
Calkin AC; Thomas MC; Cooper ME
Curr Opin Investig Drugs; 2003 Apr; 4(4):444-8. PubMed ID: 12808885
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic applications of the insulin-like growth factors.
Savage MO; Camacho-Hübner C; Dunger DB
Growth Horm IGF Res; 2004 Aug; 14(4):301-8. PubMed ID: 15231299
[TBL] [Abstract][Full Text] [Related]
12. CLX-0901 (Calyx Therapeutics).
Barlocco D
Curr Opin Investig Drugs; 2001 May; 2(5):650-3. PubMed ID: 11569941
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor-I treatment of growth disorders, diabetes mellitus and insulin resistance.
Ranke MB
Trends Endocrinol Metab; 2005; 16(4):190-7. PubMed ID: 15860416
[TBL] [Abstract][Full Text] [Related]
14. E1-INT (Transition Therapeutics/Novo Nordisk).
von Herrath M
Curr Opin Investig Drugs; 2005 Oct; 6(10):1037-42. PubMed ID: 16259225
[TBL] [Abstract][Full Text] [Related]
15. Saxagliptin, a dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.
Gallwitz B
IDrugs; 2008 Dec; 11(12):906-17. PubMed ID: 19051153
[TBL] [Abstract][Full Text] [Related]
16. APD-356 (Arena).
Jandacek RJ
Curr Opin Investig Drugs; 2005 Oct; 6(10):1051-6. PubMed ID: 16259227
[TBL] [Abstract][Full Text] [Related]
17. Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes: focus on sitagliptin.
Herman GA; Stein PP; Thornberry NA; Wagner JA
Clin Pharmacol Ther; 2007 May; 81(5):761-7. PubMed ID: 17392725
[TBL] [Abstract][Full Text] [Related]
18. Managlinat dialanetil, a fructose-1,6-bisphosphatase inhibitor for the treatment of type 2 diabetes.
Wang Y; Tomlinson B
Curr Opin Investig Drugs; 2007 Oct; 8(10):849-58. PubMed ID: 17907062
[TBL] [Abstract][Full Text] [Related]
19. DiaPep277 (DeveloGen).
Giannoukakis N
Curr Opin Investig Drugs; 2005 Oct; 6(10):1043-50. PubMed ID: 16259226
[TBL] [Abstract][Full Text] [Related]
20. Inhaled insulin: new technology, new possibilities.
Bellary S; Barnett AH
Int J Clin Pract; 2006 Jun; 60(6):728-34. PubMed ID: 16805759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
